Trial Profile
The Safety and Efficacy of Neoadjuvant Chemotherapy using Apatinib plus SOX in Local Advanced Gastric Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Jul 2019
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary) ; Rivoceranib (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 15 Jul 2019 Planned number of patients changed from 30 to 29.
- 15 Jul 2019 Status changed from recruiting to completed.
- 05 Jun 2018 Results (n=20) presented at the 54th Annual Meeting of the American Society of Clinical Oncology